Changes in antibody titer after SARS-CoV-2 vaccination of patients with in-center and home dialysis

Changes in antibody titer after SARS-CoV-2 vaccination of patients with in-center and home dialysis - Changes in antibody titer after SARS-CoV-2 vaccination of patients with in-center and home dialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046281

Enrollment

100

Registered

2021-12-05

Start date

2021-07-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Dialysis patients who regularly visited the study center or home dialysis patients who are regularly examined by the attending physician. 2) Patients who received the first vaccine dose in June 2021.

Exclusion criteria

Exclusion criteria: 1)Patients who have been infected with SARS-CoV-2. 2)Patients who received only one vaccine dose.

Design outcomes

Primary

Measure	Time frame
Changes in spike protein antibody titer	—

Secondary

Measure	Time frame
Changes in antibody titer of patients with in-center dialysis Changes in antibody titer of patients with home dialysis Analysis of factors that affect changes in spike protein antibody titer	—

Countries

Japan

Contacts

Public ContactHaruki Wakai

Reiseikai Medical Corporation Shinagawa Garden Clinic N/A

umin@reiseikai.org03-3779-4970

Outcome results